Please ensure Javascript is enabled for purposes of website accessibility
Now accepting applications for SPARK™ - Albireo’s Grants in Rare Liver Disease program. Learn more.
Science & Medicine

Medicines

Bylvay® (odevixibat)

LEARN MORE

Elobixibat

LEARN MORE

Bylvay® (odevixibat) is approved for the treatment of pruritus in PFIC in the U.S. and for PFIC in Europe. Elobixibat is approved for chronic constipation in Japan and Thailand. All other drugs and indications are currently investigational.